ATE399552T1 - 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür - Google Patents
8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafürInfo
- Publication number
- ATE399552T1 ATE399552T1 AT05730069T AT05730069T ATE399552T1 AT E399552 T1 ATE399552 T1 AT E399552T1 AT 05730069 T AT05730069 T AT 05730069T AT 05730069 T AT05730069 T AT 05730069T AT E399552 T1 ATE399552 T1 AT E399552T1
- Authority
- AT
- Austria
- Prior art keywords
- hydroxy
- üäethyl
- quinolinonemonohydrochloride
- methylethylü
- methoxyphenyl
- Prior art date
Links
- -1 AMINO Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04007045 | 2004-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE399552T1 true ATE399552T1 (de) | 2008-07-15 |
Family
ID=34963779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05730069T ATE399552T1 (de) | 2004-03-24 | 2005-03-24 | 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür |
Country Status (30)
Country | Link |
---|---|
US (1) | US20070197586A1 (de) |
EP (1) | EP1729773B1 (de) |
JP (1) | JP2007530489A (de) |
KR (1) | KR20070001946A (de) |
CN (2) | CN101812017A (de) |
AR (1) | AR048339A1 (de) |
AT (1) | ATE399552T1 (de) |
AU (1) | AU2005224032A1 (de) |
BR (1) | BRPI0508213A (de) |
CA (1) | CA2560650A1 (de) |
CY (1) | CY1108323T1 (de) |
DE (1) | DE602005007871D1 (de) |
DK (1) | DK1729773T3 (de) |
EA (1) | EA010128B1 (de) |
ES (1) | ES2309739T3 (de) |
HR (1) | HRP20080495T3 (de) |
IL (1) | IL178227A0 (de) |
MA (1) | MA28549B1 (de) |
MX (1) | MXPA06010515A (de) |
NO (1) | NO20064274L (de) |
NZ (1) | NZ550010A (de) |
PE (1) | PE20060159A1 (de) |
PL (1) | PL1729773T3 (de) |
PT (1) | PT1729773E (de) |
RS (1) | RS50602B (de) |
SI (1) | SI1729773T1 (de) |
TN (1) | TNSN06249A1 (de) |
UA (1) | UA86221C2 (de) |
WO (1) | WO2005089760A1 (de) |
ZA (1) | ZA200607907B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1953143A1 (de) * | 2007-01-30 | 2008-08-06 | CHIESI FARMACEUTICI S.p.A. | Verfahren zur Herstellung von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1H)-Chinolinon-Monohydrochlorid |
EP2116537A1 (de) * | 2008-05-07 | 2009-11-11 | CHIESI FARMACEUTICI S.p.A. | Polymorph von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-chinolinon Monohydrochlorid |
EP2116536A1 (de) * | 2008-05-07 | 2009-11-11 | CHIESI FARMACEUTICI S.p.A. | Kristallform von 8-Hydroxy-5-[(1r)-1-Hydroxy-2[[(1r)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1h)-Chinolinon-Monohydrochlorid |
WO2011015289A1 (en) | 2009-08-04 | 2011-02-10 | Chiesi Farmaceutici S.P.A. | 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl] amino]ethyl]-2(1h)-quinolinone hemi-fumarate |
EP2360147A1 (de) | 2010-02-22 | 2011-08-24 | CHIESI FARMACEUTICI S.p.A. | Verfahren zur Herstellung von kristallinen Partikeln von einem Salz von 8-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-chinolinon (Carmoterol) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
GB9603237D0 (en) * | 1996-02-16 | 1996-04-17 | Sandoz Ltd | Organic compounds |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
EP1654001A2 (de) * | 2003-08-05 | 2006-05-10 | Boehringer Ingelheim International GmbH | Medikamente zur inhalation mit steroiden und einem betamimetikum |
EP1953143A1 (de) * | 2007-01-30 | 2008-08-06 | CHIESI FARMACEUTICI S.p.A. | Verfahren zur Herstellung von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1H)-Chinolinon-Monohydrochlorid |
EP2116537A1 (de) * | 2008-05-07 | 2009-11-11 | CHIESI FARMACEUTICI S.p.A. | Polymorph von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-chinolinon Monohydrochlorid |
EP2116536A1 (de) * | 2008-05-07 | 2009-11-11 | CHIESI FARMACEUTICI S.p.A. | Kristallform von 8-Hydroxy-5-[(1r)-1-Hydroxy-2[[(1r)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1h)-Chinolinon-Monohydrochlorid |
-
2005
- 2005-03-23 PE PE2005000338A patent/PE20060159A1/es not_active Application Discontinuation
- 2005-03-23 AR ARP050101185A patent/AR048339A1/es not_active Application Discontinuation
- 2005-03-24 SI SI200530320T patent/SI1729773T1/sl unknown
- 2005-03-24 PT PT05730069T patent/PT1729773E/pt unknown
- 2005-03-24 RS RSP-2008/0393A patent/RS50602B/sr unknown
- 2005-03-24 CA CA002560650A patent/CA2560650A1/en not_active Abandoned
- 2005-03-24 AT AT05730069T patent/ATE399552T1/de not_active IP Right Cessation
- 2005-03-24 MX MXPA06010515A patent/MXPA06010515A/es active IP Right Grant
- 2005-03-24 DK DK05730069T patent/DK1729773T3/da active
- 2005-03-24 CN CN200910173473A patent/CN101812017A/zh active Pending
- 2005-03-24 EP EP05730069A patent/EP1729773B1/de active Active
- 2005-03-24 CN CN2005800076387A patent/CN1929840B/zh not_active Expired - Fee Related
- 2005-03-24 BR BRPI0508213-7A patent/BRPI0508213A/pt not_active IP Right Cessation
- 2005-03-24 AU AU2005224032A patent/AU2005224032A1/en not_active Abandoned
- 2005-03-24 WO PCT/EP2005/003144 patent/WO2005089760A1/en active Application Filing
- 2005-03-24 NZ NZ550010A patent/NZ550010A/en unknown
- 2005-03-24 EA EA200601531A patent/EA010128B1/ru not_active IP Right Cessation
- 2005-03-24 UA UAA200609448A patent/UA86221C2/uk unknown
- 2005-03-24 ES ES05730069T patent/ES2309739T3/es active Active
- 2005-03-24 DE DE602005007871T patent/DE602005007871D1/de active Active
- 2005-03-24 PL PL05730069T patent/PL1729773T3/pl unknown
- 2005-03-24 US US10/593,571 patent/US20070197586A1/en not_active Abandoned
- 2005-03-24 JP JP2007504359A patent/JP2007530489A/ja not_active Withdrawn
- 2005-03-24 KR KR1020067015966A patent/KR20070001946A/ko not_active Application Discontinuation
-
2006
- 2006-08-04 TN TNP2006000249A patent/TNSN06249A1/en unknown
- 2006-09-21 IL IL178227A patent/IL178227A0/en not_active IP Right Cessation
- 2006-09-21 ZA ZA2006/07907A patent/ZA200607907B/en unknown
- 2006-09-21 NO NO20064274A patent/NO20064274L/no not_active Application Discontinuation
- 2006-10-23 MA MA29409A patent/MA28549B1/fr unknown
-
2008
- 2008-09-04 CY CY20081100962T patent/CY1108323T1/el unknown
- 2008-10-01 HR HR20080495T patent/HRP20080495T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20070001946A (ko) | 2007-01-04 |
EP1729773B1 (de) | 2008-07-02 |
PL1729773T3 (pl) | 2008-12-31 |
CY1108323T1 (el) | 2014-02-12 |
CN1929840A (zh) | 2007-03-14 |
EA200601531A1 (ru) | 2007-04-27 |
WO2005089760A1 (en) | 2005-09-29 |
MXPA06010515A (es) | 2007-03-30 |
NZ550010A (en) | 2010-08-27 |
MA28549B1 (fr) | 2007-04-03 |
EA010128B1 (ru) | 2008-06-30 |
DE602005007871D1 (de) | 2008-08-14 |
ES2309739T3 (es) | 2008-12-16 |
US20070197586A1 (en) | 2007-08-23 |
DK1729773T3 (da) | 2008-10-20 |
TNSN06249A1 (en) | 2007-12-03 |
NO20064274L (no) | 2006-10-13 |
ZA200607907B (en) | 2008-04-30 |
EP1729773A1 (de) | 2006-12-13 |
PE20060159A1 (es) | 2006-04-04 |
JP2007530489A (ja) | 2007-11-01 |
SI1729773T1 (sl) | 2008-10-31 |
BRPI0508213A (pt) | 2007-07-17 |
AU2005224032A1 (en) | 2005-09-29 |
CN1929840B (zh) | 2010-12-08 |
CN101812017A (zh) | 2010-08-25 |
HRP20080495T3 (en) | 2008-11-30 |
IL178227A0 (en) | 2006-12-31 |
UA86221C2 (en) | 2009-04-10 |
PT1729773E (pt) | 2008-09-29 |
AR048339A1 (es) | 2006-04-19 |
RS50602B (sr) | 2010-05-07 |
CA2560650A1 (en) | 2005-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1743015E (pt) | Composição tensioactiva, processo de preparação e produto cosmético que compreende a dita composição | |
DE602006009036D1 (de) | Hängendes Bauelement und Herstellungsverfahren | |
ATE450346T1 (de) | Schleifartikel und herstellungsverfahren dafür | |
TWI310040B (en) | Polymethacrylate and production process thereof | |
ATE518856T1 (de) | Herstellverfahren | |
PL1757582T3 (pl) | Aryloalkiloaminy i sposób ich wytwarzania | |
DE602005003722D1 (de) | Feine Legierungspartikel mit unebenen Oberflächen und zugehöriges Herstellungsverfahren | |
EP1820538A4 (de) | Kosmetika und herstellungsverfahren dafür | |
DE60324888D1 (de) | und Herstellungsverfahren | |
DE602006007660D1 (de) | Duroplastische Zusammensetzung und Herstellungsverfahren | |
EP1974791A4 (de) | Wabenstruktur und herstellungsverfahren dafür | |
PL1868770T3 (pl) | Sposób tworzenia strukturalnych artykułów ściernych | |
DE602006001238D1 (de) | Filter und dessen Herstellungsmethode | |
HK1112162A1 (en) | Wig and method of manufacturing the same | |
DE602005020537D1 (de) | Koplanarer Filter und zugehöriges Herstellungsverfahren | |
IL228730A (en) | Pharmaceutical manufacturing process | |
FR2866894B1 (fr) | Poudre nouvelle traitee en surface | |
EP1837413A4 (de) | Roll-gleit-elemente und herstellungsverfahren dafür | |
ZA200802313B (en) | Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics | |
EP1799461A4 (de) | Verfahren zur herstellung von düsenplatten | |
GB0615308D0 (en) | Improved two-part microwell plates and methods of fabricating same | |
DE112006003255A5 (de) | Walzenbürste und ihre Herstellungsverfahren | |
ATE399552T1 (de) | 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür | |
DE602005020712D1 (de) | Anschlussklemme und Herstellungsverfahren | |
IL183702A0 (en) | Difluoronucleosides and process for preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1729773 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |